Literature DB >> 11956205

Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Marie Francoise Simon1, Astrid Rey, Isabelle Castan-Laurel, Sandra Grés, David Sibrac, Philippe Valet, Jean Sébastien Saulnier-Blache.   

Abstract

Because of its production by adipocytes and its ability to increase preadipocyte proliferation, lysophosphatidic acid (LPA) could participate in the paracrine control of adipose tissue development. The aim of the present study was to determine which enzyme activities are involved in exogenous LPA hydrolysis by preadipocytes and adipocytes. Using a quantitative method, we observed that extracellular LPA rapidly disappeared from the culture medium of 3T3F442A preadipocytes. This disappearance was strongly slowed down in the presence of the phosphatase inhibitors, sodium vanadate and sodium pervanadate. By using [(33)P]LPA on intact 3T3F442A preadipocytes, we found that 90% of LPA hydrolysis resulted from LPA phosphatase activity biochemically related to previously described ectolipid phosphate phosphohydrolases (LPPs). Quantitative real time reverse transcriptase-PCR revealed that 3T3F442A preadipocytes expressed mRNAs of three known Lpp gene subtypes (1, 2, and 3), with a predominant expression of Lpp1 and Lpp3. Differentiation of 3T3F442A preadipocytes into adipocytes led to an 80% reduction in ecto-LPA phosphatase activity, with a concomitant down-regulation in Lpp1, Lpp2, and Lpp3 mRNA expression. Despite this regulation, treatment of 3T3F442A adipocytes with sodium vanadate increased LPA production in the culture medium, suggesting the involvement of ecto-LPA phosphatase activity in the control of extracellular production of LPA by adipocytes. In conclusion, these data demonstrate that hydrolysis of extracellular LPA by preadipocytes and adipocytes mainly results from a dephosphorylation activity. This activity (i) occurs at the extracellular face of cell membrane, (ii) exhibits biochemical characteristics similar to those of the LPP, (iii) is negatively regulated during adipocyte differentiation, and (iv) plays an important role in the control of extracellular LPA production by adipocytes. Ecto-LPA phosphatase activity represents a potential target to control adipose tissue development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956205      PMCID: PMC2000479          DOI: 10.1074/jbc.M201530200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.

Authors:  S Bétuing; P Valet; S Lapalu; D Peyroulan; G Hickson; D Daviaud; M Lafontan; J S Saulnier-Blache
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

Review 2.  Adipogenesis and obesity: rounding out the big picture.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase.

Authors:  M Kai; I Wada; S i Imai; F Sakane; H Kanoh
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations.

Authors:  K Liliom; D J Fischer; T Virág; G Sun; D D Miller; J L Tseng; D M Desiderio; M C Seidel; J R Erickson; G Tigyi
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Properties of phosphatidate phosphohydrolase in rat adipose tissue.

Authors:  S C Jamdar; W F Cao
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

6.  Identification and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplification of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase.

Authors:  M Kai; I Wada; S Imai; F Sakane; H Kanoh
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

7.  Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

Authors:  P Valet; C Pagès; O Jeanneton; D Daviaud; P Barbe; M Record; J S Saulnier-Blache; M Lafontan
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Identification and characterization of an ecto-(lyso)phosphatidic acid phosphatase in PAM212 keratinocytes.

Authors:  M Xie; M G Low
Journal:  Arch Biochem Biophys       Date:  1994-07       Impact factor: 4.013

9.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

10.  Swiss 3T3 cells preferentially incorporate sn-2-arachidonoyl monoacylglycerol into sn-1-stearoyl-2-arachidonoyl phosphatidylinositol.

Authors:  C M Simpson; H Itabe; C N Reynolds; W C King; J A Glomset
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

View more
  9 in total

1.  Phospholipase C activity affinity purifies with the Torpedo nicotinic acetylcholine receptor.

Authors:  Jonathan M Labriola; Corrie J B daCosta; Shuzhi Wang; Daniel Figeys; Jeffrey C Smith; R Michel Sturgeon; John E Baenziger
Journal:  J Biol Chem       Date:  2010-02-04       Impact factor: 5.157

2.  A 16.7 kb deletion in Sipa1l3 is associated with juvenile cataract in mice.

Authors:  Lianna R Walker; Emily R Tosky; Kylee M Sutton; Rhonda Griess; Marytza D Abebe; Sarah Y Barnes; Tom Cunnigham; Stephen D Kachman; Merlyn K Nielsen; Daniel C Ciobanu
Journal:  Mamm Genome       Date:  2017-09-26       Impact factor: 2.957

Review 3.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 4.  Lipid phosphate phosphatases and signaling.

Authors:  David N Brindley; Carlos Pilquil
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

5.  Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation.

Authors:  Niina Aaltonen; Marko Lehtonen; Katri Varonen; Gemma Arrufat Goterris; Jarmo T Laitinen
Journal:  BMC Pharmacol       Date:  2012-06-11

6.  Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1.

Authors:  Cliona M Stapleton; Douglas G Mashek; Shuli Wang; Cynthia A Nagle; Gary W Cline; Philippe Thuillier; Lisa M Leesnitzer; Lei O Li; Julie B Stimmel; Gerald I Shulman; Rosalind A Coleman
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

7.  Lipid phosphate phosphatase 3 regulates adipocyte sphingolipid synthesis, but not developmental adipogenesis or diet-induced obesity in mice.

Authors:  Lorenzo Federico; Liping Yang; Jason Brandon; Manikandan Panchatcharam; Hongmei Ren; Paul Mueller; Manjula Sunkara; Diana Escalante-Alcalde; Andrew J Morris; Susan S Smyth
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

8.  Lysophosphatidic acid induces neointima formation through PPARgamma activation.

Authors:  Chunxiang Zhang; Daniel L Baker; Satoshi Yasuda; Natalia Makarova; Louisa Balazs; Leonard R Johnson; Gopal K Marathe; Thomas M McIntyre; Yong Xu; Glenn D Prestwich; Hoe-Sup Byun; Robert Bittman; Gabor Tigyi
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

9.  Synaptogyrin-2 influences replication of Porcine circovirus 2.

Authors:  Lianna R Walker; Taylor B Engle; Hiep Vu; Emily R Tosky; Dan J Nonneman; Timothy P L Smith; Tudor Borza; Thomas E Burkey; Graham S Plastow; Stephen D Kachman; Daniel C Ciobanu
Journal:  PLoS Genet       Date:  2018-10-31       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.